PL348640A1 - Use of parvovirus capsid particles in the inhibition of cell proliferation and migration - Google Patents

Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Info

Publication number
PL348640A1
PL348640A1 PL99348640A PL34864099A PL348640A1 PL 348640 A1 PL348640 A1 PL 348640A1 PL 99348640 A PL99348640 A PL 99348640A PL 34864099 A PL34864099 A PL 34864099A PL 348640 A1 PL348640 A1 PL 348640A1
Authority
PL
Poland
Prior art keywords
migration
inhibition
cell proliferation
parvovirus capsid
capsid particles
Prior art date
Application number
PL99348640A
Other languages
English (en)
Inventor
Kristina Broliden
Magnus Westgren
Original Assignee
Kristina Broliden
Magnus Westgren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kristina Broliden, Magnus Westgren filed Critical Kristina Broliden
Publication of PL348640A1 publication Critical patent/PL348640A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL99348640A 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration PL348640A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804022A SE520177C2 (sv) 1998-11-24 1998-11-24 Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller

Publications (1)

Publication Number Publication Date
PL348640A1 true PL348640A1 (en) 2002-06-03

Family

ID=20413393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99348640A PL348640A1 (en) 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Country Status (14)

Country Link
EP (1) EP1131085A2 (is)
JP (1) JP2003516927A (is)
KR (1) KR20010080518A (is)
CN (1) CN1328469A (is)
AU (1) AU2566600A (is)
CA (1) CA2352043A1 (is)
CZ (1) CZ20011369A3 (is)
HU (1) HUP0104298A2 (is)
IS (1) IS5931A (is)
MX (1) MXPA01004949A (is)
NO (1) NO20012534L (is)
PL (1) PL348640A1 (is)
SE (1) SE520177C2 (is)
WO (1) WO2000030668A2 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124523T2 (de) 2001-07-10 2007-09-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
EP1791858B1 (en) * 2004-09-24 2010-04-21 Intercell AG Modified vp1-capsid protein of parvovirus b19
CN101475942B (zh) * 2008-11-28 2012-05-23 中国人民解放军第四军医大学 一种b19病毒vp1独特区基因
US9598468B2 (en) 2011-05-18 2017-03-21 University Of Florida Research Foundation, Incorporated Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002839C (en) * 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
NL8902301A (nl) * 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.

Also Published As

Publication number Publication date
CZ20011369A3 (cs) 2001-10-17
JP2003516927A (ja) 2003-05-20
WO2000030668A3 (en) 2000-11-09
AU2566600A (en) 2000-06-13
CA2352043A1 (en) 2000-06-02
NO20012534L (no) 2001-06-29
WO2000030668A9 (en) 2001-04-05
CN1328469A (zh) 2001-12-26
IS5931A (is) 2001-05-02
EP1131085A2 (en) 2001-09-12
KR20010080518A (ko) 2001-08-22
SE9804022L (sv) 2000-05-25
WO2000030668A8 (en) 2000-09-14
HUP0104298A2 (hu) 2002-03-28
NO20012534D0 (no) 2001-05-23
SE520177C2 (sv) 2003-06-03
WO2000030668A2 (en) 2000-06-02
SE9804022D0 (sv) 1998-11-24
MXPA01004949A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
SG55368A1 (en) Abrasive composition and use of the same
GB9815271D0 (en) Particles and devices comprising particles
HUP0201887A2 (en) Conditioned cell culture medium compositions and methods of use
IL139786A0 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
HRP970680B1 (en) New ketobenzamides and their use
PL335424A1 (en) Heterocyclic compounds and their application in inhibiting beta-amyloid peptide secretion
IL138502A0 (en) Cell differentiation/ proliferation and maintenaince factor and uses thereof
SG69979A1 (en) Porous absorbent materials having modified surface characteristics and methods for making the same
GB2327669B (en) Coated aggregate particles for use in construction and methods of making same
ZA200101933B (en) Novel composition and use
EP0930540A4 (en) PHOTOSENSITIVE COMPOSITION AND USE THEREOF
HUP0000595A2 (en) Mixture of alkoxylates with an antifoaming disinfectant effect and the use thereof in cleaning materials
HU9900840D0 (en) Mixtures of pastes based on cellulose and the use thereof in coatings
GB9504316D0 (en) Absorbent materials and uses thereof
DE69812256D1 (de) 7-propyl-benzodiosepin-3-one und dessen Verwendung in Parfümerie
NO20012534D0 (no) Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering
GB9815270D0 (en) Particles and devices comprising particles
AU4706199A (en) Compositions and methods for inducing apoptosis in e6-expressing cells
GB9812068D0 (en) Prosthesis with centraliser and centraliser for use therewith
GB2351904B (en) Herbal composition and use of the composition for treating viral infection of the liver
GB9423267D0 (en) Compounding elements and use thereof
IL132312A0 (en) Use of leptin in inhibition of endothelial cell proliferation
HUP0104954A3 (en) Prv-1 gene and the use thereof
AU3340399A (en) Use of urocortin and like polypeptides in therapy
GB9724752D0 (en) Improvements in the holding and control of hedgecutters